Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 32.65
+0.21 (0.65%)
May 12, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 10.25 billion as of May 12, 2026. Its market cap has decreased by -2.69% in one year.
Market Cap
10.25B
Enterprise Value
11.70B
Revenue
1.93B
Ranking
n/a
PE Ratio
33.17
Stock Price
32.65
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 10.25B, a decrease of -37.94%. That is a compound annual growth rate of -9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 10.25B | -13.95% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | 16.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 11.47B |
| Chongqing Genrix Biopharmaceutical | 11.39B |
| Pacific Shuanglin Bio-pharmacy | 11.31B |
| Chengdu Easton Biopharmaceuticals | 11.28B |
| HitGen | 10.98B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.45B |
| Daan Gene | 10.25B |
| Liaoning Chengda Biotechnology | 10.17B |